Cardiac Metabolic Modulator Treatment for Improvement of Diastolic Function in Patients With Coronary Heart Disease

NCT03887013 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

226

Enrollment

OTHER_GOV

Sponsor class

Conditions

Coronary Heart Disease
Diastolic Dysfunction

Interventions

DRUG: Trimetazidine

Sponsor

China National Center for Cardiovascular Diseases